AU1246399A - Vectors inhibiting or delaying the binding of an immunodeficiency vi rus to cells - Google Patents
Vectors inhibiting or delaying the binding of an immunodeficiency vi rus to cellsInfo
- Publication number
- AU1246399A AU1246399A AU12463/99A AU1246399A AU1246399A AU 1246399 A AU1246399 A AU 1246399A AU 12463/99 A AU12463/99 A AU 12463/99A AU 1246399 A AU1246399 A AU 1246399A AU 1246399 A AU1246399 A AU 1246399A
- Authority
- AU
- Australia
- Prior art keywords
- rus
- immunodeficiency
- delaying
- vectors
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714672A FR2771423A1 (en) | 1997-11-21 | 1997-11-21 | Recombinant viral vector expressing polypeptide that inhibits viral binding |
FR9714672 | 1997-11-21 | ||
PCT/FR1998/002503 WO1999027122A1 (en) | 1997-11-21 | 1998-11-23 | Vectors inhibiting or delaying the binding of an immunodeficiency virus to cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1246399A true AU1246399A (en) | 1999-06-15 |
Family
ID=9513666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU12463/99A Abandoned AU1246399A (en) | 1997-11-21 | 1998-11-23 | Vectors inhibiting or delaying the binding of an immunodeficiency vi rus to cells |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1246399A (en) |
FR (1) | FR2771423A1 (en) |
WO (1) | WO1999027122A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
US7025968B2 (en) | 2000-08-30 | 2006-04-11 | Chemocentryx, Inc. | CMV vaccines |
EP1364037A4 (en) | 2001-02-02 | 2005-08-03 | Chemocentryx Inc | Methods and compositions useful for stimulating an immune response |
US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
EP1723178A4 (en) | 2004-03-12 | 2007-12-12 | Human Genome Sciences Inc | Human g-protein chemokine receptor (ccr5) hdgnr10 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012635A2 (en) * | 1992-11-17 | 1994-06-09 | Icos Corporation | Novel seven transmembrane receptors |
EP0869812B1 (en) * | 1995-11-30 | 2004-03-24 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | C-c chemokines that inhibit retrovirus infection |
WO1997028258A1 (en) * | 1996-01-30 | 1997-08-07 | The National Institutes Of Health | Cells expressing both human cd4 and cxcr4 |
ATE280826T1 (en) * | 1996-03-01 | 2004-11-15 | Euroscreen Sa | CC CHEMOKINCEPTOR C-C CKR-5, DERIVATIVES THEREOF AND USES |
AU728512B2 (en) * | 1996-04-02 | 2001-01-11 | Progenics Pharmaceuticals, Inc. | Method for preventing HIV-1 infection of CD4+ cells |
FR2748938B1 (en) * | 1996-05-22 | 1998-07-31 | Pasteur Institut | USE OF ANTAGONIST MOLECULES OF CHEMOKINES FOR THEIR ANTIVIRAL ACTIVITY IN PARTICULAR AGAINST HIV-TYPE RETROVIRUSES |
AU3375697A (en) * | 1996-05-28 | 1998-01-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Cc chemokine receptor 5, antibodies thereto, transgenic animals |
FR2751658B1 (en) * | 1996-07-26 | 1998-10-02 | Pasteur Institut | USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES |
US6214540B1 (en) * | 1997-03-26 | 2001-04-10 | University Of Maryland Biotechnology Institute | Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
WO1999006561A2 (en) * | 1997-07-29 | 1999-02-11 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health | Chemokine receptor ccr8 dna and uses thereof |
-
1997
- 1997-11-21 FR FR9714672A patent/FR2771423A1/en not_active Withdrawn
-
1998
- 1998-11-23 WO PCT/FR1998/002503 patent/WO1999027122A1/en active Application Filing
- 1998-11-23 AU AU12463/99A patent/AU1246399A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2771423A1 (en) | 1999-05-28 |
WO1999027122A1 (en) | 1999-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6337698A (en) | Fractional cell sorter | |
AU7961198A (en) | Towable carrying case | |
IL109008A0 (en) | Immunoassy for determination of cells | |
AU4002497A (en) | Peptide coated dendritic cells as immunogens | |
AU3081899A (en) | Viral vector directed to predetermined target cells | |
AU5483398A (en) | Lamination adhesives | |
AU4851397A (en) | Compositions for the preparation of leather | |
AU3769097A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
AU4296397A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
AU8674398A (en) | Low temperature lamination of wood | |
AU4967697A (en) | Oxygenic heterocyclic compounds | |
AU9742098A (en) | Autophobic hairspray compositions | |
AU1246399A (en) | Vectors inhibiting or delaying the binding of an immunodeficiency vi rus to cells | |
AU5416998A (en) | Preparation for the enhancement of the antioxidant status of cells | |
AU6839298A (en) | Slimming cosmetic compositions | |
AU7638498A (en) | Cyanoguanidines as cell proliferation inhibitors | |
AU5495898A (en) | Novel z-valacyclovir crystals | |
AUPN784796A0 (en) | Supplementation of glucocorticoids | |
AU646081B3 (en) | Connecting piece for large umbrellas | |
AU6839198A (en) | Slimming cosmetic compositions | |
AU7954998A (en) | Cyclin related proteins | |
AU2696597A (en) | Hydrophobic carbomer complex compositions | |
AU2143395A (en) | Rucksack having one or more movable modules | |
AU3276697A (en) | Cell compositions | |
AU3977397A (en) | An intermediate useful in the synthesis of pesticidal uracils |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |